CLINICAL_TRIALS
trial_result
· 2010-10-21
Clinical Trial Update: SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System [Phase 3]
Summary
Phase 3 SPIRIT IV trial evaluating the XIENCE V Everolimus-eluting stent system for coronary artery disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-10-21